Your browser doesn't support javascript.
loading
T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.
Takashima, S; Martin, M L; Jansen, S A; Fu, Y; Bos, J; Chandra, D; O'Connor, M H; Mertelsmann, A M; Vinci, P; Kuttiyara, J; Devlin, S M; Middendorp, S; Calafiore, M; Egorova, A; Kleppe, M; Lo, Y; Shroyer, N F; Cheng, E H; Levine, R L; Liu, C; Kolesnick, R; Lindemans, C A; Hanash, A M.
Afiliación
  • Takashima S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Martin ML; Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Jansen SA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Fu Y; Division of Pediatrics, Regenerative Medicine Center, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, Netherlands.
  • Bos J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Chandra D; Division of Pediatrics, Regenerative Medicine Center, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, Netherlands.
  • O'Connor MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Mertelsmann AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Vinci P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kuttiyara J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Devlin SM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Middendorp S; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Calafiore M; Division of Pediatrics, Regenerative Medicine Center, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, Netherlands.
  • Egorova A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kleppe M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Lo Y; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Shroyer NF; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • Cheng EH; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Liu C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Kolesnick R; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
  • Lindemans CA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Hanash AM; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sci Immunol ; 4(42)2019 12 06.
Article en En | MEDLINE | ID: mdl-31811055
ABSTRACT
Despite the importance of intestinal stem cells (ISCs) for epithelial maintenance, there is limited understanding of how immune-mediated damage affects ISCs and their niche. We found that stem cell compartment injury is a shared feature of both alloreactive and autoreactive intestinal immunopathology, reducing ISCs and impairing their recovery in T cell-mediated injury models. Although imaging revealed few T cells near the stem cell compartment in healthy mice, donor T cells infiltrating the intestinal mucosa after allogeneic bone marrow transplantation (BMT) primarily localized to the crypt region lamina propria. Further modeling with ex vivo epithelial cultures indicated ISC depletion and impaired human as well as murine organoid survival upon coculture with activated T cells, and screening of effector pathways identified interferon-γ (IFNγ) as a principal mediator of ISC compartment damage. IFNγ induced JAK1- and STAT1-dependent toxicity, initiating a proapoptotic gene expression program and stem cell death. BMT with IFNγ-deficient donor T cells, with recipients lacking the IFNγ receptor (IFNγR) specifically in the intestinal epithelium, and with pharmacologic inhibition of JAK signaling all resulted in protection of the stem cell compartment. In addition, epithelial cultures with Paneth cell-deficient organoids, IFNγR-deficient Paneth cells, IFNγR-deficient ISCs, and purified stem cell colonies all indicated direct targeting of the ISCs that was not dependent on injury to the Paneth cell niche. Dysregulated T cell activation and IFNγ production are thus potent mediators of ISC injury, and blockade of JAK/STAT signaling within target tissue stem cells can prevent this T cell-mediated pathology.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre / Linfocitos T / Interferón gamma / Mucosa Intestinal Límite: Animals Idioma: En Revista: Sci Immunol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre / Linfocitos T / Interferón gamma / Mucosa Intestinal Límite: Animals Idioma: En Revista: Sci Immunol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos